NEWS ROOM
- 2023.04.11Meiji Seika Pharma Announces that it has entered into an Alliance Agreement for Distribution and Sales of ARCT-154 with CSL Seqirus. Domestic manufacturing system will be promoted by ARCALIS’ mRNA drug manufacturing facility. Topics
- 2023.02.20Teijin and Axcelead to Establish Drug Discovery Research JV Press Release
- 2023.01.26NanoCarrier and Axcelead Signed Comprehensive Collaboration Agreement Press Release
- 2022.12.23Axcelead to Present at The 41st Annual JP Morgan Healthcare Conference Topics
- 2022.12.15Meiji Seika Pharma started the Phase III Trial of “ARCT-154” Topics